> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Drug Compounding
- URL: https://www.fdaweb.com/info-collection-on-drug-compounding/
- Published: 2024-06-12T12:00:00.000Z
- Updated: 2026-09-14T14:33:08.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157162

*Federal Register* notice: FDA is seeking comments on an information collection extension entitled “Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.” The collection supports the agency’s compounding program that is intended to protect patients from unsafe, ineffective, and poor-quality compounded drugs, while preserving access to lawfully marketed compounded drugs for patients who have a medical need for them. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-06-12/pdf/2024-12783.pdf?ref=fdaweb.com).